• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Hygienic Packaging Technology

    Trends in Solid Oral Dosage Delivery

    5 Reasons Paper Has No Place in Contract Manufacturing

    Injectable Drug Delivery Trends

    Pharmaceutical Manufacturing Equipment Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Amgen to Acquire Five Prime Therapeutics for $1.9B

    Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions

    CureVac, Novartis Ink COVID Vax Mfg. Pact

    Innoforce and dMed Enter Development Collaboration

    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Reed-Lane Facility Virtual Tour

    CureVac, Novartis Ink COVID Vax Mfg. Pact

    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

    WuXi AppTec Completes OXGENE Acquisition

    Trends in Solid Oral Dosage Delivery
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reed-Lane Facility Virtual Tour

    Hygienic Packaging Technology

    Reshaping the Pharmaceutical Supply Chain

    Serialization: Level 5 Solution

    Covectra Introduces Next-Gen Serialization Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions

    Innoforce and dMed Enter Development Collaboration

    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

    Four Female Leaders Appointed to Cell & Gene CDMO

    Strata Oncology Unveils Strata PATH Trial
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Adare Pharma Solutions

    Cytovance Biologics

    Aphena Pharma Solutions

    Syngene

    Almac Group
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Syngene

    Baxter BioPharma Solutions

    Emergent BioSolutions

    Aphena Pharma Solutions

    Almac Group
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Altimmune and CDMO Vigene Enter COVID-19 Vax Pact

    Ink manufacturing agreement for AdCOVID single dose intranasal vaccine candidate.

    Related CONTENT
    • Asymchem
    • Regis Custom Pharma
    • LGM Pharma
    • Hermes Pharma
    • Experic
    Contract Pharma Staff08.03.20
    Altimmune has entered into an agreement with Vigene Biosciences to manufacture AdCOVID, Altimmune’s single-dose intranasal vaccine candidate for COVID-19. Vigene, a Rockville, MD-based contract development and manufacturing organization (CDMO), specializes in viral vectors and will deploy its capabilities to manufacture AdCOVID. Following recent positive pre-clinical data, Altimmune plans to start a Phase 1 clinical trial of AdCOVID in Q4 2020.
     
    “Vigene is a fantastic partner to advance AdCOVID into Phase 1 clinical testing and beyond,” said Vipin Garg, president and chief executive officer, Altimmune. “We believe Vigene’s deep experience in viral vector production and their collaborative, client focused approach will help facilitate Altimmune’s timeline for clinical development of AdCOVID.”
     
    Zairen Sun, president and chief executive officer, Vigene, said, “With our new state-of-the-art manufacturing facility and our expertise in viral vector production, we are well positioned to support Altimmune in their COVID-19 vaccine development efforts. In addition to our existing facility, we are in the process of expanding our capacity so that we can support Altimmune beyond clinical development into commercial scale manufacturing.”
     
    Altimmune is also initiating scale up of manufacturing of its AdCOVID vaccine for advanced clinical trials and commercial production. The company is actively engaged in discussions with additional strategic manufacturing partners with the goal of producing at least 100 million doses of AdCOVID in 2021.
     
    AdCOVID is an intranasal vaccine candidate designed to block viral infection and to provide protection against viral spread through stimulation of both mucosal and systemic neutralizing antibodies (IgA and IgG) as well as cell-mediated immunity. By stimulating mucosal immunity in the nasal cavity, a key point of entry and replication for SARS-CoV-2, AdCOVID has the potential to defend against both infection in the recipient as well as spread of the virus to others. Intranasal administration can also be accomplished more simply than an injection and may eliminate the need for highly trained medical personnel. In addition, since it is expected to have extended stability at room temperature, AdCOVID may avoid the need for costly cold chain logistics.
     
    In preclinical studies conducted in collaboration with the University of Alabama at Birmingham (UAB), AdCOVID stimulated both strong serum neutralizing activity and potent mucosal immunity (IgA) in the respiratory tract. Additionally, vaccination of mice with AdCOVID caused the rapid recruitment of immune cells into the respiratory tract, draining lymph nodes and spleen consistent with induction of potent local and systemic immunity. Increases in CD8+ and CD4+ T cells, dendritic cells and NK cells were observed in the respiratory tract, and germinal center and memory B cells as well as T follicular helper cells were observed in regional lymph nodes and the spleen. Importantly, the latter cell types have been associated in prior vaccine development research with long-lived antibody responses.
    Suggested For You
    Asymchem Asymchem
    Regis Custom Pharma Regis Custom Pharma
    LGM Pharma LGM Pharma
    Hermes Pharma Hermes Pharma
    Experic Experic
    Sekisui Sekisui
    Swiss American CDMO Expands in Texas Swiss American CDMO Expands in Texas
    Mapp Biopharma Partners with CDMO Avid Bioservices Mapp Biopharma Partners with CDMO Avid Bioservices
    CDMO Ology Bioservices Gets $106.3M U.S. Army Contract CDMO Ology Bioservices Gets $106.3M U.S. Army Contract
    Maravai LifeSciences Expands CDMO Capabilities at TriLink Maravai LifeSciences Expands CDMO Capabilities at TriLink
    AGC Biologics Enters CDMO Partnership with Ono Pharmaceuticals AGC Biologics Enters CDMO Partnership with Ono Pharmaceuticals
    Swiss American CDMO Appears In 2020 Inc. 5000 List Swiss American CDMO Appears In 2020 Inc. 5000 List
    CDMO Sai Life Sciences Opens New Facility CDMO Sai Life Sciences Opens New Facility
    Beroni Signs Agreement with CDMO Genscript Biotech Beroni Signs Agreement with CDMO Genscript Biotech
    Sekisui Diagnostics Invests in Biopharma CDMO Capacity Sekisui Diagnostics Invests in Biopharma CDMO Capacity

    Related Breaking News

    • Breaking News | Industry News
      Amgen to Acquire Five Prime Therapeutics for $1.9B

      Amgen to Acquire Five Prime Therapeutics for $1.9B

      Adds Five Prime's pipeline of immuno-oncology and targeted cancer therapies to Amgen's oncology portfolio.
      Kristin Brooks 03.04.21

    • Bioanalytical Services | Breaking News
      Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions

      Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions

      Adds ‘off the shelf’ PK profiling capabilities to its portfolio.
      Charles Sternberg, Assistant Editor 03.04.21

    • Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
      CureVac, Novartis Ink COVID Vax Mfg. Pact

      CureVac, Novartis Ink COVID Vax Mfg. Pact

      Novartis to manufacture the mRNA and bulk drug product of the CVnCoV vaccine for up to 50 million doses by the end of 2021.
      Kristin Brooks 03.04.21


    • Bio News | Breaking News | Collaborations & Alliances | CRO News | Drug Development | Drug Discovery | Industry News | R&D
      Innoforce and dMed Enter Development Collaboration

      Innoforce and dMed Enter Development Collaboration

      Aims to accelerate the development of innovative therapeutics.
      Tim Wright, Editor, Contract Pharma 03.03.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

      Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

      New 25,000 sq. ft. GMP facility located College Station, TX.
      Tim Wright, Editor, Contract Pharma 03.03.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Promotions & Moves
      Four Female Leaders Appointed to Cell & Gene CDMO

      Four Female Leaders Appointed to Cell & Gene CDMO

      The Center for Breakthrough Medicines makes leadership appointments to fuel company growth.
      Tim Wright, Editor, Contract Pharma 03.03.21


    • Breaking News
      Fusion Pharmaceuticals Acquires IPN-1087

      Fusion Pharmaceuticals Acquires IPN-1087

      Expands its pipeline of potent alpha-emitting radiopharmaceuticals.
      Charles Sternberg, Assistant Editor 03.02.21

    • Breaking News | Clinical Trials
      Strata Oncology Unveils Strata PATH Trial

      Strata Oncology Unveils Strata PATH Trial

      The new platform clinical trial will evaluate FDA-approved therapies in novel biomarker profiles learned from real-world data.
      Charles Sternberg, Assistant Editor 03.02.21

    • Breaking News | Clinical Trials | CRO News | Information Technology
      Alimentiv Acquires McDougall Scientific

      Alimentiv Acquires McDougall Scientific

      Niche CRO specializes in statistical analysis, data management, reporting, and clinical trial design.
      Kristin Brooks 03.02.21


    • Breaking News | Industry News
      Q BioMed Inks Strontium89 Supply Pact

      Q BioMed Inks Strontium89 Supply Pact

      Agreement provides U.S. veterans and other federal government agencies access to Strontium89 for metastatic bone pain.
      Kristin Brooks 03.02.21

    • Breaking News | Promotions & Moves
      PCI Pharma Services Appoints SVP, CFO

      PCI Pharma Services Appoints SVP, CFO

      Tom De Weerdt brings more than 20 years of experience in financial leadership roles at large, global corporations.
      Kristin Brooks 03.02.21

    • Breaking News | Industry News
      AbbVie Opts to Acquire Mitokinin

      AbbVie Opts to Acquire Mitokinin

      Following completion of IND enabling studies on Mitokinin's lead PINK1 compound for Parkinson's disease.
      Kristin Brooks 03.02.21


    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
      WuXi AppTec Completes OXGENE Acquisition

      WuXi AppTec Completes OXGENE Acquisition

      Expands Cell and Gene Therapy service offerings for global customers.
      Kristin Brooks 03.02.21

    • Breaking News | Promotions & Moves
      Romaco Names Sales Directors in Cologne, Bologna and Karlsruhe

      Romaco Names Sales Directors in Cologne, Bologna and Karlsruhe

      Borja Guerra, Massimiliano Cesarini and Ralph Augenstein join the sales and service teams.
      Kristin Brooks 03.02.21

    • Breaking News | Promotions & Moves
      Impel NeuroPharma Expands Commercial Team

      Impel NeuroPharma Expands Commercial Team

      Prepares for the potential launch of TRUDHESA for the acute treatment of migraine headaches, pending FDA approval.
      Kristin Brooks 03.02.21

    Trending
    • Catalent Acquires Delphi Genetics
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • AbbVie Opts To Acquire Mitokinin
    • Four Female Leaders Appointed To Cell & Gene CDMO
    • WuXi AppTec Completes OXGENE Acquisition
    Breaking News
    • Amgen to Acquire Five Prime Therapeutics for $1.9B
    • Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions
    • CureVac, Novartis Ink COVID Vax Mfg. Pact
    • Innoforce and dMed Enter Development Collaboration
    • Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Hygienic Packaging Technology
    • Trends in Solid Oral Dosage Delivery
    • 5 Reasons Paper Has No Place in Contract Manufacturing
    • Injectable Drug Delivery Trends
    • Pharmaceutical Manufacturing Equipment Trends
    • Oral Solids: Market & Technology Trends
    • Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow
    • 2021 Contract Manufacturing Survey
    • Small Molecule Development Trends
    • Challenges & Opportunities Facing Small & Emerging Biopharma Companies
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    IFT Transitions 2021 Annual Event to Digital Experience
    NY Federal Judge Enters Permanent Injunction Against Dietary Supplement Manufacturer
    Statins May Contribute to Vascular Calcification by Inhibiting Vitamin K-Dependent Proteins
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies Adds Benjamin Woeste as Territory Sales Manager
    Maroon Group Acquires Cary Company's Raw Materials, Specialty Chemicals Distribution Business
    Matt Fogel Named Mule-Hide's Territory Manager – Southern Virginia
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    EchoNous Expands Its Kosmos Hardware Platform
    Medtronic Begins Trial to Assess Novel Ablation Tech to Treat AFib
    Europe's Cross-Border Medtech Deal Activity Rises in Q4 2020
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Amgen to Acquire Five Prime Therapeutics for $1.9B
    Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions
    CureVac, Novartis Ink COVID Vax Mfg. Pact
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Estée Lauder Establishes Equity and Engagement Center of Excellence
    L'Oreal On How It Will Shape Beauty's Future at Today's Transparency Summit
    C.O. Bigelow Earns Praise as NYC's Oldest Family-Run Apothecary
    Happi

    Latest Breaking News From Happi

    Avon Launches Vegan Skin Care Line
    Inolex Appoints VP Marketing
    Decorté Launches AI Diagnostics in US
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Henkel publishes 30th Sustainability Report
    Avery Dennison Smartrac launches new Circus Pro inlays
    Springfield Solutions highlights digital label embellishments
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FPInnovations Develops Biodegradable Mask
    Sani Professional Sanitizing and Disinfecting Products Approved by EPA
    Autefa Solutions Offers Fully Automated Line for Protective Mask Production
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Bioventus Appoints Managing Director, China and Asia Pacific
    Full-Year Sales Down 12 Percent at Zimmer Biomet
    Lincotek Medical Expands Coatings and Additive Capacity
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login